scispace - formally typeset
R

R. Phillips Heine

Researcher at Duke University

Publications -  61
Citations -  1803

R. Phillips Heine is an academic researcher from Duke University. The author has contributed to research in topics: Pregnancy & Medicine. The author has an hindex of 19, co-authored 55 publications receiving 1489 citations. Previous affiliations of R. Phillips Heine include Society for Maternal-Fetal Medicine & University of Pittsburgh.

Papers
More filters
Journal ArticleDOI

Lower genital tract infection and endometritis: Insight into Subclinical pelvic inflammatory disease

TL;DR: Subclinical PID was more common in women with lower genital tract infection than in uninfected women, and additional prospective studies are necessary to determine the reproductive impact of these asymptomatic upper genital tract infections.
Journal ArticleDOI

Placenta Accreta Spectrum.

TL;DR: Optimal management involves a standardized approach with a comprehensive multidisciplinary care team accustomed to management of placenta accreta spectrum, which outcomes are optimized when delivery occurs at a level III or IV maternal care facility before the onset of labor or bleeding and with avoidance of placental disruption.
Journal ArticleDOI

Nicotine replacement and behavioral therapy for smoking cessation in pregnancy.

TL;DR: The addition of NRT to CBT promoted smoking cessation in pregnant women but this effect did not persist postpartum and more data are needed to determine safety parameters and to confirm the efficacy of N RT use during pregnancy.
Journal ArticleDOI

Obstetric Surgical Site Infections: 2 Grams Compared With 3 Grams of Cefazolin in Morbidly Obese Women.

TL;DR: In this multicenter retrospective cohort study of morbidly obese pregnant women undergoing cesarean delivery, preoperative 3 g cefazolin prophylaxis administered to morbidly obesity gravid patients did not reduce surgical site infections.
Journal ArticleDOI

Designing Drug Trials: Considerations for Pregnant Women

TL;DR: This document summarizes the recommendations of a panel of experts convened by the Division of Microbiology and Infectious Diseases at the National Institute of Allergy andinfectious Diseases to develop strategies for addressing issues related to the development of preclinical and clinical drug studies in pregnant women.